Meet the Councilor | Director: Aaron Drucker, MD ScM FRCPC 

Dr. Aaron Drucker is an IEC Councilor who recently joined our Board of Directors. A dermatologist and researcher, he is an associate professor in the Division of Dermatology at the University of Toronto and a scientist at the Women's College Hospital Research Institute in Toronto, ON, Canada. He leads an international team conducting a living network meta-analysis of systemic immunomodulatory treatments for eczema, providing up-to-date information to patients and clinicians through EczemaTherapies.com 

How do your personal or professional vision and/or mission align(s) with the IEC vision/mission?

My research focuses on providing reliable answers to questions patients and clinicians face on a day-to-day basis. Whether it’s comparing the efficacy of new systemic treatments or evaluating the long-term safety of topical corticosteroids, I try to inform shared decision-making to improve patient care globally.

What is your proudest accomplishment in the atopic dermatitis (AD) space?

Creating a living network meta-analysis of systemic treatments for atopic dermatitis. That project has helped clinicians and patients understand the relative efficacy of new treatments that have been approved since 2017.

What do you value most about being involved with the IEC?

Being part of a community of experts with the shared goal of improving research and care for atopic dermatitis. The atopic dermatitis research community is full of amazing colleagues, and the IEC brings us together.

What do you think will garner the most attention over the coming year in this field?

New treatments—can we get closer to our goal of getting the majority of our patients clear with minimal itch?

What do you see as the biggest need among AD patients?

The biggest need is to have a treatment that provides clear skin with minimal itch for the majority of patients who use it. Psoriasis treatment has come a bit farther than atopic dermatitis treatment – but we are getting there.

What's the most recent good thing you watched, listened to, or visited?

Say Nothing